During the call, they will review your symptoms, goals, and health history, answer general questions, and discuss whether a full provider evaluation may be an appropriate next step
Specific GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in people with type 2 diabetes who have established cardiovascular disease or high cardiovascular risk
It is used to support fat metabolism and steady energy as part of a broader weight management plan, not as a standalone weight loss treatment
Suggested starting points to discuss with your clinician Deficiency without malabsorption: 1,0002,000 mcg oral cyanocobalamin daily until normalized, then weekly or monthly maintenance per labs (AAFP)
reduced soreness Week 4-6 Significant improvement in chronic injuries